YOLFTbeta
Avecho Biotechnology Ltd

Avecho Biotechnology Ltd

AVE · AU · Healthcare / Biotechnology

0.01AUD-0.00 (-9.09%)

Price History

Full chart

Market Stats

Previous Close0.011
Open0.011
Day Range0.01 – 0.011
52-Week Range0.005 – 0.027
Volume1.01M
Market Cap77.27M
P/E (TTM)0.00
Forward P/E4.78
EPS0.00
Dividend Yield0.00%
Beta1.13
50-Day Avg0.0206
200-Day Avg0.0143

About

Avecho Biotechnology Limited, a biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India. It operates through Production and Human Health segments. The company manufactures and sells TPM and Vital ET products for use in drug delivery and cosmetic formulations. Its human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. In addition, the company develops pharmaceutical products; oral, topical, and edible pharmaceutical cannabinoid products, including a cannabidiol TPM soft-gel capsule in Phase III clinical trial for the treatment of insomnia; and non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Paul Gavin BSc (Hons), Ph.D.
  • Employees0
  • HeadquartersHallmarc Business Park, Clayton, VIC, Australia, 3168, Australia
  • Websitehttps://avecho.com.au

Leadership

  • Dr. Paul Gavin BSc (Hons), Ph.D.Chief Executive Officer
  • Dr. Roksan Libinaki Ph.D.Chief Operating Officer
  • Ms. Naomi LawrieCompany Secretary

Financials

Income Statement

Currency: AUD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---------139.01K240.20K290.00K184.00K1.38M1.59M1.69M670.00K4.66M2.52M1.53M1.38M2.05M2.19M1.59M1.15M1.25M4.24M384.63K793.60K1.13M473.55K1.13M1.24M
Growth (%)----------+72.79%+20.73%-36.55%+649.46%+15.01%+6.75%-60.43%+595.52%-46.01%-39.19%-10.07%+49.20%+6.67%-27.49%-27.58%+8.87%+238.50%-90.92%+106.33%+42.26%-58.06%+139.26%+9.25%
Cost of Revenue----------24.00K-6.00K201.00K59.00K115.00K228.00K44.00K1.04M733.00K752.00K461.00K683.04K329.16K93.75K553.32K1.85M143.72K285.66K336.14K517.35K460.75K486.48K
Gross Profit---------139.01K-24.00K-178.00K1.18M1.53M1.58M442.00K4.62M1.48M551.00K624.00K1.39M1.51M1.26M1.06M698.99K4.02M240.91K507.94K793.12K-43.80K671.93K751.29K
Gross Margin---------100.00%-9.99%-96.74%85.42%96.28%93.21%65.97%99.06%58.66%36.01%45.35%67.51%68.81%79.28%91.91%55.83%94.95%62.64%64.00%70.25%-9.25%59.31%60.70%
Operating Expense---------1.17M984.00K-7.95M9.93M13.39M12.39M9.84M9.65M14.73M16.27M18.56M14.09M15.62M10.55M10.12M6.02M2.45M3.63M5.06M3.86M4.55M5.63M6.76M
Operating Income2.33M-1.09M38.36M-6.73M-46.10M-7.72M1.01M-2.35M-1.08M-1.03M-1.01M-1.45M-7.77M-8.75M-11.86M-10.81M-9.40M-5.04M-13.26M-15.72M-17.93M-12.70M-14.12M-9.29M-9.06M-5.33M1.57M-3.39M-4.55M-3.06M-4.59M-4.96M-6.00M
Operating Margin----------738.77%-419.65%-498.97%-4221.20%-634.66%-747.86%-638.75%-1402.99%-108.05%-526.83%-1027.52%-1303.27%-618.56%-644.52%-584.89%-787.74%-425.32%37.09%-880.59%-573.46%-271.39%-969.06%-437.69%-485.09%
EBITDA2.33M-1.09M38.36M-6.73M-46.10M-7.72M1.01M-2.35M1.74M-999.00K-744.00K-1.43M-7.70M-8.59M-11.67M-9.96M-8.93M-4.81M-11.31M-10.80M-14.05M-8.92M-10.85M-9.56M-9.04M-4.60M1.20M-2.45M-2.98M-2.11M-3.24M-2.92M-5.87M
EBITDA Margin----------718.63%-309.74%-491.72%-4186.41%-623.13%-735.88%-588.07%-1333.43%-103.30%-449.56%-706.21%-1021.08%-434.29%-495.30%-601.89%-785.74%-367.41%28.27%-637.66%-375.25%-186.54%-684.83%-257.72%-474.02%
Net Income816.00K-341.00K17.62M-3.10M-21.69M-3.86M503.57K-1.17M-5.37M-4.35M-2.66M-3.15M-7.32M-6.13M-8.84M-91.21M-8.50M-11.28M1.11M-11.05M-12.67M-8.94M-20.12M-17.31M-8.62M-3.99M849.96K-2.63M-3.42M-2.34M-3.44M-3.12M-4.42M
Net Income Margin----------3128.46%-1108.23%-1085.52%-3979.89%-444.16%-557.63%-5387.24%-1268.81%-241.95%43.96%-722.55%-921.00%-435.22%-918.72%-1090.30%-749.39%-318.77%20.06%-685.08%-430.44%-207.44%-725.79%-275.55%-356.82%
R&D------------3.07M4.75M8.45M6.39M3.45M2.97M4.92M3.15M4.36M3.38M4.31M2.83M2.27M1.03M166.04K187.60K2.13M1.59M2.12M3.59M4.31M
R&D as % of Total Revenue------------1670.65%344.74%532.53%377.38%514.93%63.71%195.71%205.95%316.93%164.78%196.62%178.15%197.04%82.59%3.92%48.77%268.90%141.19%447.05%316.95%348.30%
Interest Expense000000009.65M8.47M4.32M4.54M4.63M00204.74M017.50M531.00K0000110.00K36.00K90.52K11.03K5.92K9.97K6.35K15.36K57.13K461.36K
Interest Expense % of Total Revenue---------6096.36%1796.40%1564.83%2514.13%0.00%0.00%12093.50%0.00%375.58%21.10%0.00%0.00%0.00%0.00%6.93%3.13%7.23%0.26%1.54%1.26%0.56%3.24%5.04%37.27%

Balance Sheet

Currency: AUD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets11.88M11.19M34.48M33.01M5.52M1.62M5.10M20.86M18.40M14.84M29.41M114.03M171.07M173.49M171.52M69.19M67.36M53.77M76.58M64.12M42.96M50.90M30.74M13.35M8.24M4.80M5.32M3.35M5.25M3.35M7.32M5.00M7.11M
Total Liabilities1.46M380.00K5.58M5.84M73.48K33.16K72.16K185.25K56.42K30.35K25.12K810.73K38.94M38.02M37.76M17.64M17.38M14.76M3.63M1.51M2.19M1.87M1.82M1.71M1.84M902.04K556.13K700.17K709.36K920.66K941.54K1.73M5.55M
Total Equity10.42M10.81M28.90M27.18M5.45M1.59M5.02M20.67M18.34M14.81M29.38M113.22M132.18M135.47M133.76M51.55M49.99M39.01M72.95M62.61M40.77M49.03M28.93M11.65M6.40M3.90M4.76M2.65M4.54M2.42M6.38M3.27M1.56M
Cash147.00K296.00K81.00K183.00K1.05K153.15K2.24M4.23M3.28M2.20M2.31M7.22M13.19M14.43M10.71M12.90M10.87M2.74M27.20M16.91M8.82M20.68M12.39M6.09M2.90M2.11M3.21M1.87M3.26M1.47M5.50M2.37M4.66M
Total Debt--1.00K-----39.19K-----------------97.19K166.23K93.91K246.07K175.15K1.08M14.47K
Net Debt-147.00K-296.00K-80.00K-183.00K-1.05K-153.15K-2.24M-4.23M-3.24M-2.20M-2.31M-7.22M-13.19M-14.43M-10.71M-12.90M-10.87M-2.74M-27.20M-16.91M-8.82M-20.68M-12.39M-6.09M-2.90M-2.11M-3.11M-1.71M-3.17M-1.22M-5.33M-1.30M-4.65M

Cash Flow

Currency: AUD1993-12-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow23.00K-1.22M-1.43M-2.94M-3.78M-406.45K-337.79K-819.60K-939.40K-898.56K-831.60K-1.36M-4.55M-8.12M-10.86M-7.23M-8.96M-8.34M-9.29M-11.66M-8.58M-6.74M-8.71M-6.41M-6.42M-2.19M1.19M-1.42M-3.10M-1.67M-3.18M-3.97M1.10M
Investing Cash Flow-7.08M-508.00K749.00K1.68M3.63M558.55K-512.57K-14.01M-10.15K-1.01M-4.00M431.96K-57.00K48.00K213.00K641.00K347.00K211.00K1.11M1.06M455.00K390.00K421.00K108.80K53.53K41.85K11.06K-5.15K-202.82K-53.12K0-15.73K0
Financing Cash Flow8.74M338.00K468.00K1.37M-33.23K-2.93M16.83M1.53K816.25K4.95M5.84M10.57M9.30M6.93M8.77M6.59M-32.64M315.00K34.00K18.20M3.17M3.17M3.17M1.36M-89.44K-82.50K4.69M-78.22K7.22M854.59K1.19M
Capital Expenditure00000019.07K148.19K10.15K5.25K013.67K390.00K489.00K816.00K235.00K76.00K131.00K79.00K184.00K133.00K95.00K89.00K62.28K55.59K4245.15K5.15K202.82K53.12K500
Free Cash Flow23.00K-1.22M-1.43M-2.94M-3.78M-406.45K-356.85K-967.79K-949.55K-903.81K-831.60K-1.37M-4.94M-8.60M-11.67M-7.47M-9.04M-8.47M-9.37M-11.85M-8.71M-6.83M-8.79M-6.47M-6.48M-2.19M1.19M-1.43M-3.30M-1.72M-3.18M-3.97M1.10M
Dividends Paid-453.00K178.00K1.12K280.77K-----------------------4.40M----
FCF to OCF100.00%100.00%100.00%100.00%100.00%100.00%105.64%118.08%101.08%100.58%100.00%101.01%108.57%106.03%107.52%103.25%100.85%101.57%100.85%101.58%101.55%101.41%101.02%100.97%100.87%100.02%100.00%100.36%106.55%103.19%100.00%100.00%100.00%
Dividend Paid to FCF--37.16%-12.42%-0.04%-7.42%------------------------133.25%----

Earnings

Report DateAug 28, 2014Feb 29, 2016Aug 29, 2016Feb 28, 2017Aug 31, 2017Feb 26, 2018Aug 13, 2018Feb 27, 2019Aug 29, 2019Mar 1, 2020Aug 28, 2020Feb 26, 2021Aug 26, 2021Feb 24, 2022Aug 29, 2022Mar 15, 2023Mar 6, 2025Aug 28, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.000.000.00-0.010.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Surprise------------------
Timing--------------Pre-marketAfter-hoursAfter-hours-

Key Statistics & Ratios

Market Cap77.27M
Enterprise Value74.62M
Trailing P/E0.00
Forward P/E4.78
Price / Sales104.81
Price / Book42.54
EPS0.00
Book Value0.00
Revenue (TTM)737.29K
Gross Profit (TTM)537.55K
EBITDA-3.10M
Profit Margin0.00%
Operating Margin-3144.96%
Return on Equity-268.21%
Return on Assets-25.82%
Shares Outstanding3.86B
Shares Float2.45B
Beta1.13
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20102×
0.03Sep 22, 20100.02Feb 26, 2010
20092×
0.02Sep 30, 20090.02Feb 26, 2009
20082×
0.04Sep 30, 20080.04Feb 29, 2008
20072×
0.04Oct 2, 20070.04Mar 2, 2007
20062×
0.04Oct 6, 20060.04Mar 9, 2006
20051×
0.06Nov 3, 2005
20041×
0.03Dec 2, 2004
19971×
0.01May 15, 1997
19951×
0.00Oct 23, 1995
19942×
0.01Sep 30, 19940.00Apr 21, 1994

Stock Splits

  • Sep 29, 201785:83
  • Apr 23, 1999968:721